Correlation of the dysmetabolic risk factors with different anthropometric measurements

Endocrine Journal

Volumn 52, Issue 1, 2005, Pages 139-148

  Chiou, Wen Ko ^a   Lin, Jen Der ^a,c   Weng, Hsiao Fen ^a   Ou, Yung Chun ^a   Liu, Thu Hua ^b   Fang, Ji Tseng ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b MING CHI UNIVERSITY OF TECHNOLOGY   (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Body mass index; Dyslipidemia; Leptin; Metabolic index; Waist hip ratio

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IMMUNOREACTIVE INSULIN; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID;

ADULT; AGED; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH CARE MANAGEMENT; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; HYPERTENSION; HYPERURICEMIA; INSULIN BLOOD LEVEL; LASER MICROSCOPY; LIPID BLOOD LEVEL; MALE; METABOLIC PARAMETERS; RISK FACTOR; TAIWAN; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; WAIST CIRCUMFERENCE; WHOLE BODY SCINTISCANNING;

ADULT; AGED; AGED, 80 AND OVER; ANTHROPOMETRY; BODY MASS INDEX; BODY WEIGHTS AND MEASURES; FEMALE; HUMANS; HYPERLIPIDEMIAS; IMAGING, THREE-DIMENSIONAL; INCIDENCE; INSULIN; LASERS; LEPTIN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RISK FACTORS; WAIST-HIP RATIO;

EID: 15744378529     PISSN: 09188959     EISSN: None     Source Type: Journal    
DOI: 10.1507/endocrj.52.139     Document Type: Article

References (35)

1. Garaulet M, Perex-Llamas F, Fuente T, Zamora S, Tebar FJ (2000) Anthropometric, computed tomography and fat cell data in an obese population: relationship with insulin, leptin, tumor necrosis factor-alpha, sex hormone-binding globulin and sex hormones. Eur J Endocrinol 143: 657-666.
2. Modan M, Halkin H (1991) Hyperinsulinemia or increased sympathetic drive as links for obesity and hypertension. Diabetes Care 14: 470-487.
3. Reaven GM, Lithell H, Landsberg L (1996) Hypertension and associated metabolic abnormalities: the role of insulin resistance and the sympathoadrenal system. N Eng J Med 334: 374-381.
4. Bays H, Mandarino L, DeFronzo RA (2004) Mechanism of endocrine disease: role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach. J Clin Endocrinol Metab 89: 463-478.
5. Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Morales PA, Stern MP (1992) Prospective analysis of the insulin-resistance syndrome (Syndrome X). Diabetes 41: 715-722.
6. Bao W, Srinivasan SR, Wattifney WA, Berenson GS (1994) Persistence of multiple cardiovascular risk clustering related to Syndrome X from childhood to young adulthood: The Bogalusa Heart Study. Arch Intern Med 154: 1842-1847.
7. Chen W, Bao W, Begum S, Elkasabany A, Srinivasan SR, Berenson GS (2000) Age-related patterns of the clustering of cardiovascular risk variables of syndrome X from childhood to young adulthood in population made up of black and white subjects: the Bogalusa Heart Study. Diabetes 49: 1042-1048.
8. Jeppesen J, Hein HO, Suadicani P, Gyntelberg F (2000) High triglycerides and low HDL cholesterol and blood pressure and risk of ischemic heart disease. Hypertension 36: 226-232.
9. Haffner SM, Ferrannini E, Hazuda HP, Stern MP (1992) Clustering of cardiovascular risk factors in confirmed prehypertensive individuals. Hypertension 20: 38-45.
10. Srinivasan SR, Bao W, Berenson GS (1993) Coexistence of increased levels of adiposity, insulin, and blood pressure in a young adult cohort with elevated very-low-density lipoprotein cholesterol: The Bogalusa Heart Study. Metabolism 42: 170-176.
11. Meigs JB, D'Agostino RB, Wilson PW, Cupples LA, Nathan DM, Singer DE (1997) Risk variable clustering in the insulin resistance syndrome: The Framingham Offspring Study. Diabetes 46: 1594-1600.
12. Mykkanen L, Haffner SM, Ronnemaa T, Bergman RN, Laakso M (1997) Low insulin sensitivity is associated with clustering of cardiovascular disease risk factors. Am J Epidemiol 146: 315-321.
13. Bacha F, Saad R, Gungor Janosky J, Arslanian SA (2003) Obesity, regional fat distribution, and syndrome X in obese black versus white adolescents: race differential in diabetogenic and atherogenic risk factors. J Clin Endocrinol Metab 88: 2534-2540.
14. Lin JD, Chiou WK, Weng HF, Tsai YH, Liu TH (2002) Comparison of three-dimensional anthropometric body surface scanning with waist hip ratio and body mass index in correlation of metabolic risk factors. J Clin Epidemiol 55: 757-766.
15. Coombes AM, Moss JP, Linney AD, Richards R, James DR (1991) A mathematical method for the comparison of 3D changes in the facial surface. Eur J Orthodontic 13: 95-110.
16. Jones PRM, Baker AJ, Hardy CJ, Mowat AP (1994) The measurement of body surface area in children with liver disease by a novel 3D body scanning device. Eur J Appl Physiol 68: 514-518.
17. Pi-Sunyer XF (1998) Clinical guidelines on the identification, evaluation and treatment of overweight and obesity in adults -the evidence report. Obes Res 6: 51S-210S.
18. Laurier D, Guiguet M, Chau NP, Wells JA, Valleron AJ (1992) Prevalence of obesity: a comparative survey in France, the United Kindom and the United States. Int J Obes Relat Metab Disord 16: 565-572.
19. Berenson GS, McMahan CA, Voors AW (1980) Cardiovascular risk factors in children: the early natural history of atherosclerosis and essential hypertension. New York, NY: Oxford University.
20. Guidelines Subcommittee (1999) World Health Organization-International Society of Hypertension guidelines for the management of hypertension. J Hypertension 17: 151-183.
21. Allain CC, Poon LS, Chan CS, Richmond W, Fu PC (1974) Enzymatic determination of total serum cholesterol. Clin Chem 20: 470-475.
22. Bucolo G, David H (1973) Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem 19: 476-482.
23. Haffner SM, Miettinen H, Stern MP (1997) The homeostasis model in the San Antonio Heart Study. Diabetes Care 20: 1087-1092.
24. Liu TH, Ciou WK, Lin JD, Yu CY (2001) Implementation of whole body scanner for determining somatotype index at Chang Gung Memorial Hospital. Chang Gung Med J 24: 697-707.
25. SAS Institute, Inc. (1990) SAS/STAT user's guide, version 6.4th ed. Cary, NC: SAS Institute.
26. Kissebah A, Vydelingum N, Murray R, Evans DJ, Hurtz AJ, Kalkhoff PK, Adams PW (1982) Relationship of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab 54: 254-260.
27. Larsson B, Svärdsudd K, Welin L, Wilhelmsen L, Bjorntorp P, Tibblin G (1984) Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and health: 13 year follow up of participants in the Study of Men Born in 1913. Br Med J 288: 1401-1404.
28. Reaven GM (2003) Insulin resistance/compensatory hyperinsulinemia, essential hypertension, and cardiovascular disease. J Clin Endocrinol Metab 88: 2399-2403.
29. Sandhofer A, Laimer M, Ebenbichler CF, Kaser S, Paulweber B, Patsch JR (2003) Soluble leptin receptor and soluble receptor-bound fraction of leptin in the metabolic syndrome. Obes Res 11: 760-768.
30. Goldstone AP, Brynes AE, Thomas EL, Bell JD, Frost G, Holland A, Ghatei MA, Bloom SR (2002) Resting metabolic rate, plasma leptin concentrations, leptin receptor expression, and adipose tissue measured by whole-body magnetic resonance imaging in women with Prader-Willi syndrome. Am J Clin Nutr 75: 468-475.
31. He M, Li ETS, Kung AWC (1999) Dual-energy X-ray absorptiometry for body composition estimation in Chinese women. Eur J Clin Nutr 53: 933-937.
32. Paccaud F, Schlüter-Fasmeyer V, Wietlisbach V, Bovet P (2000) Dyslipidemia and abdominal obesity: an assessment in three general populations. J Clin Epidemiol 53: 393-340.
33. Hu FB, Wang B, Chen C, Jin Y, Yang J, Stampfer MJ, Xu X (2000) Body mass index and cardiovascular risk factors in rural Chinese. Am J Epidemiol 151: 88-97.
34. Tsai ST, Li CL, Chen CH, Chou P (2000) Community-based epidemiological study of glucose tolerance in Kin-Chen, Kinmen: support for a new intermediate classification. J Clin Epidemiol 53: 505-510.
35. Lin KC, Lin HY, Chou P (2000) The interaction between uric acid level and other risk factors on the development of gout among asymptomatic hyperuricemia men in a prospective study. J Rheumatol 27: 1501-1505.